Efficacy of Chest CT for COVID-19 Pneumonia Diagnosis in France.

Guillaume Herpe,Mathieu Lederlin,Mathieu Naudin,Mickaël Ohana,Kathia Chaumoitre,Jules Gregory,Valérie Vilgrain,Cornelia Anna Freitag,Constance De Margerie-Mellon, Violaine Flory, Marie Ludwig, Lydiane Mondot,Isabelle Fitton,Alexis Raymond Robert Jacquier, Paul Ardilouze,Isabelle Petit,Alban Gervaise, Olivier Bayle, Arielle Crombe, Magloire Mekuko Sokeng, Clément Thomas, Geraldine Henry, Virginie Bliah,Thomas Le Tat,Marc-Samir Guillot, Paul Gendrin,Marc Garetier, Estelle Bertolle, Catherine Montagne, Benjamin Langlet, Abdulrazak Kalaaji, Hampar Kayayan, Florian Desmots, Benjamin Dhaene,Pierre-Jean Saulnier,Remy Guillevin,Jean-Michel Bartoli,Jean-Paul Beregi,Jean Pierre Tasu

Radiology(2020)

引用 89|浏览14
暂无评分
摘要
Background The role and performance of chest CT in the diagnosis of the coronavirus disease 2019 (COVID-19) pandemic remains under active investigation. Purpose To evaluate the French national experience using chest CT for COVID-19, results of chest CT and reverse transcription polymerase chain reaction (RT-PCR) assays were compared together and with the final discharge diagnosis used as the reference standard. Materials and Methods A structured CT scan survey (NCT04339686) was sent to 26 hospital radiology departments in France between March 2, 2020, and April 24, 2020. These dates correspond to the peak of the national COVID-19 epidemic. Radiology departments were selected to reflect the estimated geographic prevalence heterogeneities of the epidemic. All symptomatic patients suspected of having COVID-19 pneumonia who underwent both initial chest CT and at least one RT-PCR test within 48 hours were included. The final discharge diagnosis, based on multiparametric items, was recorded. Data for each center were prospectively collected and gathered each week. Test efficacy was determined by using the Mann-Whitney test, Student t test, χ2 test, and Pearson correlation coefficient. P < .05 indicated a significant difference. Results Twenty-six of 26 hospital radiology departments responded to the survey, with 7500 patients entered; 2652 did not have RT-PCR test results or had unknown or excess delay between the RT-PCR test and CT. After exclusions, 4824 patients (mean age, 64 years ± 19 [standard deviation], 2669 male) were included. With final diagnosis as the reference, 2564 of the 4824 patients had COVID-19 (53%). Sensitivity, specificity, negative predictive value, and positive predictive value of chest CT in the diagnosis of COVID-19 were 2319 of 2564 (90%; 95% CI: 89, 91), 2056 of 2260 (91%; 95% CI: 91, 92), 2056 of 2300 (89%; 95% CI: 87, 90), and 2319 of 2524 (92%; 95% CI: 91, 93), respectively. There was no significant difference for chest CT efficacy among the 26 geographically separate sites, each with varying amounts of disease prevalence. Conclusion Use of chest CT for the initial diagnosis and triage of patients suspected of having coronavirus disease 2019 was successful. © RSNA, 2021 Online supplemental material is available for this article.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要